IDiyas

For the Inventor, By the Inventor

Skokie, IL, United States of America

G.d. Searle & Company


USPTO Granted Patents = 1,323


Trademarks = 17

Forward Citations = 15,093

Loading Chart...
Loading Chart...

730 inventors (with patents filed for the assignee):

goldMedal Richard A Mueller (188 out of 211 patents)

silverMedal John Jeffrey Talley (118 out of 227 patents)

bronzeMedal Daniel P Getman (107 out of 170 patents)

4.  Gunnar J Hanson (107 out of 181 patents)

5.  Michael L Vazquez (97 out of 131 patents)

6.  Gary A DeCrescenzo (87 out of 139 patents)

7.  John Nicholas Freskos (76 out of 126 patents)

8.  John S Baran (72 out of 78 patents)

9.  Richard A Partis (69 out of 79 patents)

10.  Richard M Weier (62 out of 82 patents)

11.  Donald W Hansen, Jr (56 out of 73 patents)

12.  Paul Waddell Collins (54 out of 67 patents)

13.  James A Sikorski (52 out of 130 patents)

14.  Daniel L Flynn (52 out of 125 patents)

15.  Barnett S Pitzele (50 out of 64 patents)


Core Competencies:
Retroviral Protease Inhibitors
Amino Acid Derivatives
Hydroxyethylamino Sulfonamides
Sulfonyl Urea Derivatives
Anti-Inflammatory Agents
Cyclooxygenase Inhibitors
Epoxy Steroids
Combination Therapy
Cholesteryl Ester Transfer Protein
Neoplasia Treatment
Pyrazole Derivatives
Nucleic Acids

1,323 patents:

1. 7232817 - α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors (2007-06-19),
2. 7202258 - α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors (2007-04-10),
3. 7199158 - Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors (2007-04-03),
4. 7192983 - N-protected/N-substituted-beta-amino hydroxy sulfonates (2007-03-20),
5. 7189864 - Method of preparing intermediates useful in synthesis of retroviral protease inhibitors (2007-03-13),
6. 7161033 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2007-01-09),
7. 7141609 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2006-11-28),
8. 7141594 - Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2006-11-28),
9. 7138411 - Substituted benzopyran derivatives for the treatment of inflammation (2006-11-21),
10. 7135489 - Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl] benzenesulfonamide (2006-11-14),
11. 7132441 - Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor (2006-11-07),
12. 7115632 - Sulfonyl aryl or heteroaryl hydroxamic acid compounds (2006-10-03),
13. 7115618 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2006-10-03),
14. 7112683 - Cyclic sulfone containing retroviral protease inhibitors (2006-09-26),
15. 7098202 - Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2006-08-29),
G.D. Searle & Company is a pharmaceutical company that specializes in the research, development, and manufacture of innovative drugs and healthcare products. With a focus on improving people's lives and advancing healthcare, G.D. Searle & Company has become a trusted name in the industry. Their website provides comprehensive information about their products, ongoing research projects, and corporate initiatives.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

1,323 Patents

#1 in Skokie, IL

#21 in Illinois

#372 in US

#730 in the World

...
Skokie, IL, United States of America

G.d. Searle & Company

Forward Citations = 15,093

730 inventors:

goldMedal Richard A Mueller (188 out of 211 patents)

silverMedal John Jeffrey Talley (118 out of 227 patents)

bronzeMedal Daniel P Getman (107 out of 170 patents)

4.  Gunnar J Hanson (107 out of 181 patents)

5.  Michael L Vazquez (97 out of 131 patents)

Please report any incorrect information to support@idiyas.com
Loading…